T CELL MATURATION AND LIGAND QUALITY
T CELL MATURATION AND LIGAND QUALITY
批准号:
6488700
负责人:
ELI E SERCARZ
金额:
$29.26万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2002-09-30
关键词:
Adenoviridae Leishmania major MHC class II antigen T cell receptor antigen presentation bacterial antigens cell differentiation cytokine experimental allergic encephalomyelitis genetically modified animals helper T lymphocyte laboratory mouse ligands myelin basic proteins protein biosynthesis tissue /cell culture transfection /expression vector vaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The failure to resolve infectious diseases as well as to fight autoimmune
diseases often results from inappropriate, rather than from insufficient,
immune responses. Thus, it is critical for vaccine design to be able to
manipulate the type of response induced. We are proposing a comprehensive
analysis of parameters that contribute to determining the direction of the
T cell cytokine secretion profile. We will explore how
dominance/crypticity, and availability/affinity affect determinant
display, as well as ways in which the mode of antigenic presentation--in
what strain, with what cytokines, by what route--combine to influence
Th1/Th2 choice. What is the relationship of immunodominance to Th1/Th2
choice and induction or protection from disease? Based on our previous
evidence that MHC-binding affinity of the determinant can impact the T
cell cytokine secretion profile, we will focus on the role of antigen
itself. We will modulate the MHC-binding affinity of determinants of the
LACK antigen or Leishmania major and of myelin basic protein (MBP), in
order to induce a Th1 or Th2 response to protect mice from L. major
infection or MBP-induced experimental allergic encephalomyelitis (EAE),
respectively. The relative importance of MHC-binding affinity, adjuvant,
cytokine milieu (including adenovirus-mediated cytokine gene delivery) and
mouse genetic background will be assessed. We will also address the impact
of such manipulations on the T cell repertoire. From Vbeta single chain
transgenic T cells, specific for peptide (161-173) of LACK, T cells with
different Valpha genes and of widely disparate affinities will be selected
and 3 new transgenic chains will be prepared expressing these TCRs. We
will determine whether both high avidity and low avidity T cells have the
capacity to affect Th1/Th2 choice in the presence of high and low MHC-
affinity ligands. Whether high and low affinity, MHC ligands address
distinct populations of T cell swill be determined using immunoscope
analysis, which allows visualization of the T cell response based on
distinct CDR3 lengths. The role of T cells specific for a subdominant
determinant within the responses based on distinct CDR3 lengths. The role
of T cells specific for a subdominant determinant within the MBP121-150
region, recruited early during determinant spreading, will be studied.
This region consists of two overlapping determinants that possess
differential MHC-binding affinities. We will analyze whether these
determinants induce T cells of overlapping common specificity versus T
cells of private or flanking specificity. This study will allow us to
define the relative roles of MHC affinity and TCR avidity in steering the
response in a protective versus an aggressive direction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
B cell regulation of diabetogenic activity
-
批准号:7196856
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2007
-
负责人:ELI E SERCARZ
-
依托单位:
B cell regulation of diabetogenic activity
-
批准号:7385968
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2007
-
负责人:ELI E SERCARZ
-
依托单位:
Degeneracy and Complexity in the Immune System
-
批准号:7059192
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2006
-
负责人:ELI E SERCARZ
-
依托单位:
PATHOGENIC AND REGULATORY AUTOIMMUNE T CELL REPERTOIRES
-
批准号:6606941
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2000
-
负责人:ELI E SERCARZ
-
依托单位:
PATHOGENIC AND REGULATORY AUTOIMMUNE T CELL REPERTOIRES
-
批准号:6374611
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2000
-
负责人:ELI E SERCARZ
-
依托单位:
PATHOGENIC AND REGULATORY AUTOIMMUNE T CELL REPERTOIRES
-
批准号:6511557
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2000
-
负责人:ELI E SERCARZ
-
依托单位:
PATHOGENIC AND REGULATORY AUTOIMMUNE T CELL REPERTOIRES
-
批准号:6191305
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2000
-
负责人:ELI E SERCARZ
-
依托单位:
Competition Among Pathogenic or Protective T Cell Clones
-
批准号:6828690
-
项目类别:
-
资助金额:$30.71万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL MATURATION AND LIGAND QUALITY
-
批准号:6137246
-
项目类别:
-
资助金额:$29.05万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
Competition Among Pathogenic or Protective T Cell Clones
-
批准号:6891332
-
项目类别:
-
资助金额:$40.95万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
Competition Among Pathogenic or Protective T Cell Clones
-
批准号:6726358
-
项目类别:
-
资助金额:$10.24万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL MATURATION AND LIGAND QUALITY
-
批准号:6626339
-
项目类别:
-
资助金额:$31.74万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
Competition Among Pathogenic or Protective T Cell Clones
-
批准号:7240572
-
项目类别:
-
资助金额:$38.83万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
Competition Among Pathogenic or Protective T Cell Clones
-
批准号:7455255
-
项目类别:
-
资助金额:$38.09万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL MATURATION AND LIGAND QUALITY
-
批准号:2758880
-
项目类别:
-
资助金额:$28.2万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
Competition Among Pathogenic or Protective T Cell Clones
-
批准号:7071656
-
项目类别:
-
资助金额:$39.99万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL MATURATION AND LIGAND QUALITY
-
批准号:6341694
-
项目类别:
-
资助金额:$29.92万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL MATURATION AND LIGAND QUALITY
-
批准号:6684862
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1999
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL RESPONSE TO MEP-REPERTOIRE AND REGULATION
-
批准号:2064447
-
项目类别:
-
资助金额:$17.05万
-
财政年份:1989
-
负责人:ELI E SERCARZ
-
依托单位:
T CELL RESPONSE TO MEP-REPERTOIRE AND REGULATION
-
批准号:2886617
-
项目类别:
-
资助金额:$23.88万
-
财政年份:1989
-
负责人:ELI E SERCARZ
-
依托单位:
海外基金